Drug Safety Information for HEPARIN LOCK FLUSH (Heparin sodium)

Safety-related Labeling Changes for HEPARIN SODIUM IN PLASTIC CONTAINER (HEPARIN SODIUM) Rx Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (HEPARIN SODIUM) Discontinued Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (HEPARIN SODIUM) Discontinued Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9% (HEPARIN SODIUM) Discontinued Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9% (HEPARIN SODIUM) Discontinued Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (HEPARIN SODIUM) Discontinued Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% (HEPARIN SODIUM) Discontinued Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (HEPARIN SODIUM) Discontinued Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45% (HEPARIN SODIUM) Discontinued Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (HEPARIN SODIUM) Discontinued Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (HEPARIN SODIUM) Discontinued Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45% (HEPARIN SODIUM) Discontinued Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER (HEPARIN SODIUM) Rx Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER (HEPARIN SODIUM) Rx Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER (HEPARIN SODIUM) Rx Drug: FDA Link

Safety-related Labeling Changes for HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (HEPARIN SODIUM) Rx Drug: FDA Link

Adverse Drug Reactions for HEPARIN LOCK FLUSH* (Heparin sodium)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with HEPARIN LOCK FLUSH
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Death2546
2Renal failure2450
3Pain*2401
4Adverse event2392
5Hypotension1974
6Heparin-induced thrombocytopenia1908
7Anxiety1894
8Injury1809
9Nausea1710
10Dyspnoea1668
11Unevaluable event1624
12Thrombocytopenia1469
13Fear1410
14Vomiting*1366
15Multi-organ failure1317
16Emotional distress1313
17Renal impairment1219
18Renal injury1205
19Pyrexia1154
20Renal failure acute1128

* This side effect also appears in "Top 10 Side Effects of HEPARIN LOCK FLUSH " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking HEPARIN LOCK FLUSH
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Product used for unknown indication21278
2Thrombosis prophylaxis7327
3Prophylaxis5983
4Anticoagulant therapy5932
5Haemodialysis2991
6Pulmonary embolism2145
7Deep vein thrombosis1901
8Intravenous catheter management1176
9Myocardial infarction1033
10Acute myocardial infarction1001

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for HEPARIN LOCK FLUSH

Total Reports Filed with FDA: 157698


Number of FDA Adverse Event Reports by Patient Age for HEPARIN LOCK FLUSH

Total Reports Filed with FDA: 157698*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Heparin sodium (Lipo-hepin, Liquaemin lock flush, Heparin, Heparin solution, Heparin sodium, Heparina, Heparin lock flush, Panheprin, Liquaemin sodium, Sodium heparin)

Charts are based on 157698 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and HEPARIN LOCK FLUSH Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.